These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1259932)

  • 41. Thrombin generates monocyte chemotactic activity from complement factor H.
    Ohtsuka H; Imamura T; Matsushita M; Tanase S; Okada H; Ogawa M; Kambara T
    Immunology; 1993 Sep; 80(1):140-5. PubMed ID: 8244456
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The identification of fibrinopeptide B as a chemotactic agent derived from human fibrinogen.
    Kay AB; Pepper DS; McKenzie R
    Br J Haematol; 1974 Aug; 27(4):669-77. PubMed ID: 4472824
    [No Abstract]   [Full Text] [Related]  

  • 43. Clotting of bovine fibrinogen. Kinetic analysis of the release of fibrinopeptides by thrombin and of the calcium uptake upon clotting at high fibrinogen concentrations.
    Mihalyi E
    Biochemistry; 1988 Feb; 27(3):976-82. PubMed ID: 3365374
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fibrinogen Milano II: a congenital dysfibrinogenaemia associated with juvenile arterial and venous thrombosis.
    Haverkate F; Koopman J; Kluft C; D'Angelo A; Cattaneo M; Mannucci PM
    Thromb Haemost; 1986 Feb; 55(1):131-5. PubMed ID: 3705000
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fibrinogen-induced erythrocyte aggregation: erythrocyte-binding site in the fibrinogen molecule.
    Maeda N; Seike M; Kume S; Takaku T; Shiga T
    Biochim Biophys Acta; 1987 Nov; 904(1):81-91. PubMed ID: 2959322
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of monocyte chemotactic protein-1 by monocytes and endothelial cells exposed to thrombin.
    Colotta F; Sciacca FL; Sironi M; Luini W; Rabiet MJ; Mantovani A
    Am J Pathol; 1994 May; 144(5):975-85. PubMed ID: 8178946
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lipopolysaccharide-instructed, cryopreserved, human monocytes sequentially convert plasma fibrinogen to fibrin and lyse the fibrin formed.
    Kierulf P; Andersen AB
    Pathobiology; 1991; 59(3):197-9. PubMed ID: 1883514
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lymphocyte suppressive peptides from fibrinogen are derived predominantly from the A alpha chain.
    Plow EF; Edgington TS
    J Immunol; 1986 Sep; 137(6):1910-5. PubMed ID: 2943807
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thrombin-induced fibrinopeptide B release from normal and variant fibrinogens: influence of inhibitors of fibrin polymerization.
    Ruf W; Bender A; Lane DA; Preissner KT; Selmayr E; Müller-Berghaus G
    Biochim Biophys Acta; 1988 May; 965(2-3):169-75. PubMed ID: 3365451
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Growth factors for human fibroblasts in the solute remaining after clot formation.
    Gray AJ; Reeves JT; Harrison NK; Winlove P; Laurent GJ
    J Cell Sci; 1990 Jun; 96 ( Pt 2)():271-4. PubMed ID: 2211868
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fibrinogen induces chemotactic activity in endothelial cells.
    Seeger FH; Blessing E; Gu L; Bornhold R; Denger S; Kreuzer J
    Acta Physiol Scand; 2002 Oct; 176(2):109-15. PubMed ID: 12354170
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Radioimmunoassay of human fibrinopeptide B and kinetics of fibrinopeptide cleavage by different enzymes.
    Bilezikian SB; Nossel HL; Butler VP; Canfield RE
    J Clin Invest; 1975 Aug; 56(2):438-45. PubMed ID: 50328
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chemotaxis of monocytes and neutrophils to platelet-derived growth factor.
    Deuel TF; Senior RM; Huang JS; Griffin GL
    J Clin Invest; 1982 Apr; 69(4):1046-9. PubMed ID: 7076844
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Monocyte and neutrophil chemotactic activity of normal and diluted human serum and plasma.
    Jungi TW
    Int Arch Allergy Appl Immunol; 1977; 53(1):18-28. PubMed ID: 838512
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thrombin and plasmin activity in coronary artery disease.
    Small M; Lowe GD; Douglas JT; Hutton I; Lorimer AR; Forbes CD
    Br Heart J; 1988 Sep; 60(3):201-3. PubMed ID: 2972304
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assay of human fibrinopeptides by high-performance liquid chromatography.
    Ebert RF; Bell WR
    Anal Biochem; 1985 Jul; 148(1):70-8. PubMed ID: 4037309
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Interaction of a peptide inhibitor with two forms of monomeric fibrin differing in the degree of activation].
    Chiriat'ev EA; Leonova OP; Byshevskiĭ ASh
    Ukr Biokhim Zh (1978); 1989; 61(1):3-9. PubMed ID: 2741239
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thrombin chemotactic stimulation of HL-60 cells: studies on thrombin responsiveness as a function of differentiation.
    Bar-Shavit R; Hruska KA; Kahn AJ; Wilner GD
    J Cell Physiol; 1987 May; 131(2):255-61. PubMed ID: 3034923
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes in pH associated with clotting of fibrinogen. Kinetic studies of the pH shift and correlation of the pH change with the release of fibrinopeptides and the ensuing polymerization.
    Mihalyi E; Tercero JC; Diaz-Mauriño T
    Biochemistry; 1991 May; 30(19):4753-62. PubMed ID: 2029517
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The in vitro inhibitory effect on thrombin by 2,3-diphosphoglycerate.
    Del Principe D; Strappini PM; Del Vecchio S; Menichelli A; Biancini G; Cosmi EV; Bastianon V; D'Arcangelo C
    Thromb Haemost; 1981 Oct; 46(3):581-3. PubMed ID: 7031980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.